Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 8 studies | 19% ± 3% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 22% ± 3% | |
intestinal crypt stem cell | 5 studies | 40% ± 18% | |
mature NK T cell | 3 studies | 22% ± 3% | |
non-classical monocyte | 3 studies | 25% ± 4% | |
extravillous trophoblast | 3 studies | 68% ± 15% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of ASCL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 91% | 136.19 | 154 / 170 | 68% | 16.90 | 311 / 459 |
intestine | 61% | 174.90 | 586 / 966 | 87% | 171.25 | 457 / 527 |
stomach | 57% | 36.16 | 205 / 359 | 84% | 149.75 | 241 / 286 |
bladder | 62% | 125.95 | 13 / 21 | 61% | 67.49 | 309 / 504 |
esophagus | 46% | 50.41 | 661 / 1445 | 74% | 31.54 | 136 / 183 |
lung | 72% | 56.30 | 415 / 578 | 47% | 14.48 | 544 / 1155 |
prostate | 92% | 208.16 | 226 / 245 | 21% | 3.60 | 104 / 502 |
breast | 66% | 65.46 | 304 / 459 | 41% | 7.95 | 462 / 1118 |
spleen | 100% | 158.12 | 240 / 241 | 0% | 0 | 0 / 0 |
kidney | 88% | 108.08 | 78 / 89 | 3% | 0.26 | 30 / 901 |
tonsil | 0% | 0 | 0 / 0 | 89% | 18.62 | 40 / 45 |
skin | 72% | 377.55 | 1304 / 1809 | 13% | 1.15 | 60 / 472 |
peripheral blood | 79% | 148.57 | 732 / 929 | 0% | 0 | 0 / 0 |
thymus | 59% | 40.80 | 388 / 653 | 17% | 8.32 | 101 / 605 |
pancreas | 54% | 29.18 | 176 / 328 | 16% | 3.86 | 29 / 178 |
lymph node | 0% | 0 | 0 / 0 | 69% | 8.30 | 20 / 29 |
liver | 60% | 32.58 | 136 / 226 | 4% | 0.54 | 16 / 406 |
ovary | 8% | 3.63 | 14 / 180 | 54% | 10.86 | 234 / 430 |
adipose | 48% | 24.79 | 582 / 1204 | 0% | 0 | 0 / 0 |
brain | 34% | 18.43 | 909 / 2642 | 2% | 0.15 | 17 / 705 |
adrenal gland | 31% | 13.57 | 80 / 258 | 2% | 2.78 | 5 / 230 |
blood vessel | 19% | 8.76 | 249 / 1335 | 0% | 0 | 0 / 0 |
heart | 4% | 1.64 | 37 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.16 | 2 / 80 |
muscle | 1% | 0.52 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045629 | Biological process | negative regulation of T-helper 2 cell differentiation |
GO_0010626 | Biological process | negative regulation of Schwann cell proliferation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0060712 | Biological process | spongiotrophoblast layer development |
GO_0001890 | Biological process | placenta development |
GO_0030182 | Biological process | neuron differentiation |
GO_2000320 | Biological process | negative regulation of T-helper 17 cell differentiation |
GO_0061470 | Biological process | T follicular helper cell differentiation |
GO_0001666 | Biological process | response to hypoxia |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0045626 | Biological process | negative regulation of T-helper 1 cell differentiation |
GO_2000406 | Biological process | positive regulation of T cell migration |
GO_0060719 | Biological process | chorionic trophoblast cell development |
GO_0007423 | Biological process | sensory organ development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035019 | Biological process | somatic stem cell population maintenance |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0043425 | Molecular function | bHLH transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0070888 | Molecular function | E-box binding |
GO_0046983 | Molecular function | protein dimerization activity |
Gene name | ASCL2 |
Protein name | Achaete-scute homolog 2 (ASH-2) (hASH2) (Class A basic helix-loop-helix protein 45) (bHLHa45) (Mash2) |
Synonyms | BHLHA45 HASH2 |
Description | FUNCTION: Transcription factor. Binds to E-box motifs 5'-CANNTG-3' in the regulatory elements of target genes, probably as a heterodimer with another basic helix-loop-helix (bHLH) protein such as the transcription factor TCF3. May bind both open and closed chromatin, acting as a pioneer transcription factor to allow other factors to bind and activate lineage-specific genes. Required during post-implantation development for the generation of some differentiated trophoblast cell types. Transcriptional activity of ASCL2 may be antagonised in a subset of trophoblast cells by bHLH transcription factor HAND1, perhaps by competing for dimerization with other bHLH proteins. Involved in differentiation and function of follicular T-helper (Tfh) cells, thereby playing a role in germinal center responses; probably modulates expression of genes involved in Tfh cell function, such as BCL6. May also act as a suppressor of Th1-, Th2- and Th17-cell differentiation. Induces the formation of stem cells in intestinal crypts in vitro, synergistically activating transcription of target genes, such as SOX9, together with TCF4/beta-catenin. May form a bistable transcriptional switch, controlling expression of its own gene together with Wnt/R-spondin signaling, and thereby maintaining stem cell characteristics (By similarity). Modulates expression of target genes, including perhaps down-regulating EGR1/Krox24 and chemokine CXCL10/Mob-1 and up-regulating CXCR4 and CDKN1C/p57kip2, in Schwann cells. May play a role in reducing proliferation of Schwann cells, perhaps acting via modulation of expression of CDKN1C (By similarity). May be dispensable for blastocyst formation and later embryonic function (By similarity). May be involved in the determination of neuronal precursors (By similarity). . |
Accessions | ENST00000331289.5 Q99929 |